ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-07-01
|
Series: | Cancer Communications |
Online Access: | https://doi.org/10.1002/cac2.12296 |
_version_ | 1828264488853307392 |
---|---|
author | Dingxie Liu Qiongyu Hao Jieqing Li Qun Li Kun Wang Qing Geng Yutong Wu Jaydutt V. Vadgama Yong Wu |
author_facet | Dingxie Liu Qiongyu Hao Jieqing Li Qun Li Kun Wang Qing Geng Yutong Wu Jaydutt V. Vadgama Yong Wu |
author_sort | Dingxie Liu |
collection | DOAJ |
first_indexed | 2024-04-13T04:26:02Z |
format | Article |
id | doaj.art-996d92ab73134f3c8c08ef9759281226 |
institution | Directory Open Access Journal |
issn | 2523-3548 |
language | English |
last_indexed | 2024-04-13T04:26:02Z |
publishDate | 2022-07-01 |
publisher | Wiley |
record_format | Article |
series | Cancer Communications |
spelling | doaj.art-996d92ab73134f3c8c08ef97592812262022-12-22T03:02:31ZengWileyCancer Communications2523-35482022-07-0142766366710.1002/cac2.12296ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patientsDingxie Liu0Qiongyu Hao1Jieqing Li2Qun Li3Kun Wang4Qing Geng5Yutong Wu6Jaydutt V. Vadgama7Yong Wu8Bluewater Biotech LLC New Providence NJ 07974 USADivision of Cancer Research and Training Department of Internal Medicine Charles Drew University of Medicine and Science David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center Los Angeles CA 90095 USADivision of Cancer Research and Training Department of Internal Medicine Charles Drew University of Medicine and Science David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center Los Angeles CA 90095 USADepartment of Oncology Shanghai East Hospital School of Medicine Tongji University Shanghai 200123 P. R. ChinaDepartment of Breast Cancer Cancer Center Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences Guangzhou Guangdong 510080 P. R. ChinaDepartment of Thoracic Surgery Renmin Hospital of Wuhan University Wuhan Hubei 430060 P. R. ChinaBluewater Biotech LLC New Providence NJ 07974 USADivision of Cancer Research and Training Department of Internal Medicine Charles Drew University of Medicine and Science David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center Los Angeles CA 90095 USADivision of Cancer Research and Training Department of Internal Medicine Charles Drew University of Medicine and Science David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center Los Angeles CA 90095 USAhttps://doi.org/10.1002/cac2.12296 |
spellingShingle | Dingxie Liu Qiongyu Hao Jieqing Li Qun Li Kun Wang Qing Geng Yutong Wu Jaydutt V. Vadgama Yong Wu ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients Cancer Communications |
title | ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients |
title_full | ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients |
title_fullStr | ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients |
title_full_unstemmed | ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients |
title_short | ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients |
title_sort | zbed2 expression enhances interferon signaling and predicts better survival of estrogen receptor negative breast cancer patients |
url | https://doi.org/10.1002/cac2.12296 |
work_keys_str_mv | AT dingxieliu zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients AT qiongyuhao zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients AT jieqingli zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients AT qunli zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients AT kunwang zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients AT qinggeng zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients AT yutongwu zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients AT jayduttvvadgama zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients AT yongwu zbed2expressionenhancesinterferonsignalingandpredictsbettersurvivalofestrogenreceptornegativebreastcancerpatients |